Silo Pharma Inc. Insider Trading

SILO

⊜ Compare

Last 12 months

Insiders bought 8K on the open market and sold nothing.

Net open-market

+8K

3 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Dec 2025

Dec 15, 2025

Get an email when SILO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 15, 2025	Eric Weisblum Chief Executive Officer	Bought 2 parts	5,000	$0.42 average	2K	2.4%	Form 4
Nov 20, 2025 – Nov 21, 2025	Eric Weisblum Chief Executive Officer	Bought 2 parts	2,000	$0.37 average	$740	1.0%	Form 4
Nov 18, 2025 – Nov 19, 2025	Eric Weisblum Chief Executive Officer	Bought 2 parts	12,000	$0.40 average	5K	6.1%	Form 4
May 27, 2025	Eric Weisblum Chief Executive Officer	Bought	10,000	$0.43	4K	5.3%	Form 4
Dec 13, 2024	Eric Weisblum CEO and President	Bought	2,500	$0.84	2K	1.3%	Form 4
Nov 20, 2024 – Nov 22, 2024	Eric Weisblum CEO and President	Bought 2 parts	5,000	$0.93 average	5K	2.8%	Form 4

Dec 15, 2025
Eric Weisblum
Chief Executive Officer · bought 5,000 at avg $0.42
2K
2.4% of stake
Nov 20, 2025 – Nov 21, 2025
Eric Weisblum
Chief Executive Officer · bought 2,000 at avg $0.37
$740
1.0% of stake
Nov 18, 2025 – Nov 19, 2025
Eric Weisblum
Chief Executive Officer · bought 12,000 at avg $0.40
5K
6.1% of stake
May 27, 2025
Eric Weisblum
Chief Executive Officer · bought 10,000 at $0.43
4K
5.3% of stake
Dec 13, 2024
Eric Weisblum
CEO and President · bought 2,500 at $0.84
2K
1.3% of stake
Nov 20, 2024 – Nov 22, 2024
Eric Weisblum
CEO and President · bought 5,000 at avg $0.93
5K
2.8% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SILO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SILO

CompareIntrinsic value

OWPCOne World Products Inc.

$0.00+0.00%46

AVTXAvalo Therapeutics Inc.

$7.07-2.48%10

ALTAltimmune, Inc.

$2.12+3.92%10

NTHINeonC Technologies Holdings

$3.17+3.26%10

BPTHBio-Path Holdings Inc.

$0.00+66.67%20

BNTCBenitec Biopharma Inc.

$9.28+10.48%10

IBOImpact Biomedical Inc.

$4.10+1.99%20

LYELLyell Immunopharma, Inc.

$15.43+43.27%10

Held by ETFs

SILO is in 1 US ETF. The largest of them, with SILO's weight in each:

PSAdvisorShares Psychedelics ETFPSIL1.06%of the fund

Spot a number that looks wrong? Check it in SILO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SILO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.